Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07455721) titled 'Central Sensitization in Women With Adenomyosis: Prevalence, Risk Factors, and Therapeutic Failure' on Feb. 26.
Study Type: Observational
Primary Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Condition:
Adenomyosis
Recruitment Status: Not recruiting
Date of First Enrollment: December 9, 2025
Target Sample Size: 1200
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrials.gov/study/NCT07455721
Published by HT Digital Content Services with permission from Health Daily Digest....